Patent details

EP3482767 Title: DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY

Basic Information

Publication number:
EP3482767
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP181993585
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY
French Title of Invention:
THÉRAPIE DE REMPLACEMENT ENZYMATIQUE D'ESCALADE DE DOSES POUR LE TRAITEMENT DU DÉFICIT EN SPHINGOMYÉLINASE ACIDE
German Title of Invention:
DOSISERHÖHUNGSENZYMERSATZTHERAPIE ZUR BEHANDLUNG DES MANGELS AN SAURER SPHINGOMYELINASE
SPC Number:
LUC00288

Dates

Filing date:
28/08/2010
Grant date:
06/10/2021
EP Publication Date:
15/05/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/10/2021
EP B1 Publication Date:
06/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/08/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/11/2022
 
 

Name:
GENZYME CORPORATION
Address:
450 Water Street, Cambridge,, 02141, Massachusetts, United States (US)

From:
29/09/2021
 
 

Name:
Icahn School of Medicine at Mount Sinai
Address:
One Gustave L. Levy Place, New York, NY 10029, United States (US)

History of Owners

From:
29/09/2021
To:
18/11/2022

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Agent

Name:
VALIPAT
From:
13/12/2021
Address:
Avenue Louise 54, 1050, Bruxelles, Belgium (BE)
To:

Inventor

1

Name:
DESNICK, Robert J.
Address:
United States (US)

2

Name:
ANDREWS, Laura P.
Address:
United States (US)

3

Name:
MURRAY, James M.
Address:
United States (US)

4

Name:
SCHUCHMAN, Edward H.
Address:
United States (US)

5

Name:
COX, Gerald F.
Address:
United States (US)

Priority

Priority Number:
238113 P
Priority Date:
28/08/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/43; A61P 3/06;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/13
Publication date:
01/12/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202140
Publication date:
06/10/2021
Description:
Grant (B1)

2

Issue number:
202145
Publication date:
10/11/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20210000524A
Date Registered:
13/12/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VALIPAT
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20220000464A
Date Registered:
18/11/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Change of address
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
Icahn School of Medicine at Mount Sinai
Address:
One Gustave L. Levy Place, New York, NY 10029, United States (US)

2

Name:
GENZYME CORPORATION
Address:
450 Water Street, Cambridge,, 02141, Massachusetts, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/08/2025
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
13/12/2021 Outgoing Correspondence 1
18/11/2022 Request For Change 2
13/12/2021 Request For Change 2
13/03/2026 Request For Change 5
16/03/2026 Outgoing Correspondence 46